Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS) New vaccine program is added to Evaxion’s ...
Cases of group A streptococcus (GAS) have been on the rise in the past decade. The bacteria can cause a range of diseases that span from mild to deadly. In addition, the bacteria are diversifying and ...
Sweden: A study published in the International Journal of Infectious Diseases found that prescribing antibiotics for ...
Group A Streptococcus (GAS), a human-specific pathogen, causes a spectrum of disease ranging from uncomplicated pharyngitis and impetigo to life-threatening invasive infections such as necrotising ...
Unlocking the link: COVID-19 restrictions tied to surge in invasive Group A Streptococcal infections
In a recent study published in Eurosurveillance, researchers investigated whether a change in variant structure might be responsible for the increased incidence of group A streptococci (GAS) ...
Breakthrough research has found that Group A Streptococcus (GAS) infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of ...
Data over a 32-year period showed that the incidence of invasive group A streptococcal (iGAS) infections in children remained stable before 2011, increased until 2020, declined during the pandemic, ...
Most Strep A infections are mild, but in rare cases the bacteria can cause serious illness The death of five-year-old Jax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results